WebApr 11, 2024 · What Makes CRISPR Therapeutics AG (CRSP) a New Buy Stock. CRISPR Therapeutics AG (CRSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting … WebApr 11, 2024 · Sam Kulkarni. CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed …
CRSP Stock News CRISPR THERAPEUTICS Stock Price Today
WebApr 6, 2024 · CRSP: Get the latest CRISPR Therapeutics stock price and detailed information including CRSP news, historical charts and realtime prices. ... Earnings … WebRepresents the company's profit divided by the outstanding shares of its common stock. -1.41. 23.37%. EBITDA. Earnings before interest, taxes, depreciation, and amortization, is a measure of a ... crans-montana ski prix
CRSP - CRISPR Therapeutics AG Stock Price and Quote
WebIt is based on a 36-month historical regression of the return on the stock onto the return on the S&P 500. Earnings: The amount and date of latest Earnings Per Share (EPS) paid out to shareholders. Dividend: Annual dividend, or portion of a company's profit paid to shareholders. Also shows the annual dividend yield percent (latest dividend rate ... WebJul 23, 2024 · In the last reported quarter, CRISPR Therapeutics reported a negative earnings surprise of 4.14%. Shares of CRISPR Therapeutics have declined 18.5% so far this year compared with the industry ’s ... Web20 hours ago · Cantor Fitzgerald initiated coverage on CRISPR Therapeutics AG (NASDAQ:CRSP) with an Overweight rating and a price target of $72, citing an interesting gene editing play for 2024.; The company has ... اسد اسد انا الاسد